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Other names: AIP5 (Atropin-1-interacting protein 5); 




The WWP1 gene encompasses 26 exons which span 
approximatively 142 kb of DNA. BAC clone RPCI-
459L5 contains the complete human WWP1 genome 
sequence. 
Transcription 
WWP1 mRNA is strongly or modestly expressed in 
human heart, muscle, placenta, kidney, liver, pancreas 
and testis (Mosser et al., 1998; Komuro et al., 2004). 
The size of the WWP1 mRNA is about 4.2 kb (Chen et 
al., 2007). There are multiple splicing isoforms in the  
breast cancer cell line T47D (Flasza et al., 2002). The 
open reading frame for the full length WWP1 gene is 
2766 bp. The transcription is increased by TGFb (Chen 
et al., 2007). 
Protein 
Description 
922 amino acids; approximatively 110 kDa protein; 
The C2 domain at N-terminus is responsible for 
calcium-dependent phospholipid binding. The four 
WW domains in the middle are responsible for protein-
protein interaction with PY motifs. The HECT domain 
at the C-terminus is responsible for the ubiquitin 
transfer. The Cystein 890 is the catalytic center. The 
underlined WWP1 substrates do not have a PY motif 
(PPXY). A smaller WWP1 protein isoform was 
detected in two prostate cancer cell lines PC-3 and 
LAPC-4 (Chen et al., 2007a). 
Protein structure: The HECT domain of WWP1 (see 
Figure 2C.) (Verdecia et al., 2003). 
 
Figure 1. Boxes represent exons. 
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Figure 2A: WWP1 protein.  
Figure 2B: Exogenous WWP1 expression in the 22Rv1 prostate cancer cell line was detected under a confocal microscopy. The 
endosomes are indicated by GFP-Rab5. 
Figure 2C: Protein structure of WWP1. 






Atlas Genet Cytogenet Oncol Haematol. 2008;12(5)  395 
Expression 
The WWP1 protein is lowly expressed in normal 
prostate and breast but is frequently upregulated in 
prostate and breast cancers due to the gene 
amplification. 
Localisation 
Predominately on membrane structures in cytoplasm 
and occasionally in nucleus (see Figure 2B.). 
Function 
WWP1 is an E3 ubiquitin ligase. 
WWP1 negatively regulates the transforming growth 
factor-beta (TGF-b) signaling by targeting its molecular 
components, including TGF-beta receptor 1 (TbR1) 
(Komuro et al., 2004), Smad2 (Seo et al., 2004), and 
Smad4 (Moren et al., 2005) for ubiquitin mediated 
degradation. 
In addition, WWP1 has been reported to target the 
epithelial Na+ channel (ENaC) (Malbert-Colas et al., 
2003), Notch (Shaye and Greenwald, 2005), Runx2 
(Jones et al., 2006; Shen et al., 2006), KLF2 (Zhang et 
al., 2004), and KLF5 (Chen et al., 2005) for ubiquitin-
mediated proteolysis. 
Recently, WWP1 has been demonstrated to inhibit p53 
activity through exporting p53 from the nucleus after 
ubiquitination (Laine and Ronai, 2007). Overall, 
WWP1 may play a pro-survival role in several tumor 
types including breast (Chen et al., 2007b) and prostate 
(Chen et al., 2007a). WWP1 has also shown to promote 
virus budding (Martin-Serrano et al., 2005; Heidecker 
et al., 2007). 
Homology 
WWP1 belongs to the C2-WW-HECT E3 family which 
contains 8 other members (Chen and Matesic, 2007). 
The WWP1 gene is highly-conserved among species 
(from human to c. elegant). 
Mutations 
Somatic 
The WWP1 gene is rarely mutated in human prostate 
cancer (Chen et al., 2007a). Two sequence alterations 
were detected in prostate cancer xenografts. One was 
2393A→T (Glu798Val) in CWR91 and the other was 
721A→T (Thr241Ser) in LuCaP35. Additionally, some 
mutations in the HECT domain decrease the E3 ligase 




The WWP1 gene is amplified in 31-44% prostate 
cancer cell lines/xenografts/tumors. Consistently, the 
WWP1 mRNA and protein is up-regulated in these 
samples compared to immortalized prostate epithelial 
cell lines. WWP1 knock-down increases the TGFb-
induced CDK inhibitor p15 expression and decreases 
PC-3 prostate cancer cell growth in vitro. These results 




The WWP1 gene is amplified in 41-51% breast cancer 
cell lines/tumors. Consistently, the WWP1 mRNA and 
protein is up-regulated in breast cancer cells compared 
to immortalized breast epithelial cell lines. WWP1 
knock-down induces growth arrest and apoptosis in 
MCF7 and HCC1500 breast cancer cell lines. Forced 
expression of WWP1 promotes MCF10A and 184B5 
immortalized breast epithelial cell proliferation in an 
E3 ligase independent manner. 
Figure 3. WWP1 protein expression in normal breast epithelial cells and breast cancer cells by immunohistochemical staining. 
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